https://rheveramed.com/about-us/news/ 2026-10-05T17:05:26+00:00 https://rheveramed.com/news/endologix-afxr-endovascular-aaa-system-receives-shonin-approval-marketing-japan/ 2015-12-11T00:55:00+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-inc-trivascular-technologies-inc-complete-merger/ 2016-02-04T00:55:22+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-announces-first-u-s-commercial-implant-afx2-bifurcated-endograft-system/ 2016-03-01T00:55:46+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-announces-first-patients-japan-treated-nellix-endovascular-aneurysm-sealing-system/ 2016-03-09T00:56:12+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-announces-ce-mark-next-generation-nellix-endovascular-aneurysm-sealing-system/ 2016-04-11T23:56:32+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/positive-nellix-clinical-data-global-registry-treatment-iliac-aneurysm-studies-presented-38th-annual-charing-cross-symposium/ 2016-04-27T23:56:51+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/positive-nellix-clinical-data-ascend-study-treatment-juxta-pararenal-aaa-presented-38th-annual-charing-cross-symposium/ 2016-04-28T23:57:10+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-completes-patient-enrollment-ovation-life-least-invasive-fast-track-evar-study/ 2016-05-16T23:57:31+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-reports-positive-clinical-data-nellix-evas-forward-ide-study/ 2016-05-26T23:57:57+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-reports-positive-clinical-data-nellix-evas-system-multicenter-study-italy/ 2016-06-09T23:58:17+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/endologix-reports-positive-clinical-data-ovation-life-least-invasive-fast-track-evar-study/ 2016-09-21T02:05:17+00:00 https://rheveramed.com/news/endologix-appoints-matthew-thompson-m-d-chief-medical-officer/ 2016-10-26T03:15:17+00:00 https://rheveramed.com/news/endologix-provides-update-nellix-pma-process-irvine/ 2016-11-17T04:14:04+00:00 https://rheveramed.com/news/positive-five-year-results-global-ovation-pivotal-trial-presented-2016-veith-symposium/ 2016-11-17T04:14:45+00:00 https://rheveramed.com/news/positive-two-year-data-nellix-evas-forward-global-registry-presented-2016-veith-symposium/ 2016-11-18T01:09:50+00:00 https://rheveramed.com/news/endologix-receives-australian-therapeutic-goods-administration-tga-approval-afx2-bifurcated-endograft-system/ 2016-12-20T03:22:07+00:00 https://rheveramed.com/news/endologix-announces-temporary-hold-afx-resolve-manufacturing-issue/ 2016-12-28T03:23:10+00:00 https://rheveramed.com/news/endologix-resumes-shipments-procedures-afx-sizes-afx2-schedules-conference-call-december-30-2016-900-et/ 2016-12-30T03:23:52+00:00 https://rheveramed.com/news/endologix-provides-physicians-updated-information-afx-endovascular-aaa-system/ 2016-12-31T03:24:42+00:00 https://rheveramed.com/news/endologix-resumes-shipments-sizes-afx2-endovascular-aaa-systems-appoints-laura-nagel-vice-president-global-quality/ 2017-01-18T03:25:28+00:00 https://rheveramed.com/news/endologix-announces-reinstatement-ce-mark-afx-afx2-endovascular-aaa-system/ 2017-01-26T03:26:06+00:00 https://rheveramed.com/news/positive-three-year-results-ovation-european-post-market-registry-presented-2017-linc-symposium/ 2017-01-26T03:26:38+00:00 https://rheveramed.com/news/endologix-announces-appointment-dan-lemaitre-chairman-board-john-mcdermott-continue-chief-executive-officer/ 2017-02-07T05:21:59+00:00 https://rheveramed.com/news/endologix-completes-patient-enrollment-ovationr-lucy-study-first-prospective-study-evaluating-evar-female-population/ 2017-02-15T02:04:41+00:00 https://rheveramed.com/news/memoriam-dr-ted-diethrich-1935-2017/ 2017-02-25T04:32:51+00:00 https://rheveramed.com/news/endologix-inc-announces-enrollment-first-patients-elevate-ide-clinical-study/ 2017-03-31T06:29:36+00:00 https://rheveramed.com/news/endologix-enters-170-million-credit-facility-deerfield-management/ 2017-04-05T05:25:18+00:00 https://rheveramed.com/news/endologix-provides-update-nellix-endovascular-aneurysm-sealing-system-u-s-regulatory-status/ 2017-05-18T03:04:59+00:00 https://rheveramed.com/news/endologix-reports-positive-clinical-data-ovation-lucy-study/ 2017-06-01T07:30:12+00:00 https://rheveramed.com/wp-content/uploads/2023/06/2017-05-31-LUCY-Clinical-Results-at-SVS-FINAL.png https://rheveramed.com/news/nellix-evas-forward-ide-trial/ 2017-06-03T22:15:25+00:00 https://rheveramed.com/news/endologix-announces-positive-clinical-results-leopard-clinical-study/ 2017-08-17T18:05:52+00:00 https://rheveramed.com/news/endologix-announces-collaboration-agreements-japan-lifeline-development-commercialization-thoracic-endovascular-systems-japan/ 2017-09-11T18:05:43+00:00 https://rheveramed.com/news/ce-mark-approval-nellix-endovascular-aneurysm-sealing-system/ 2017-09-21T19:23:57+00:00 https://rheveramed.com/news/endologix-receives-ide-approval-evas2-confirmatory-clinical-study-evaluate-nellix-endovascular-aneurysm-sealing-system/ 2017-10-06T18:05:12+00:00 https://rheveramed.com/news/endologix-appoints-john-onopchenko-chief-operating-officer/ 2017-10-19T18:05:13+00:00 https://rheveramed.com/news/veith-2017-presentation-status-leopard-trial-comparing-afx-endologix-graft-standard-evar-endografts/ 2017-11-15T07:22:42+00:00 https://rheveramed.com/news/endologix-appoints-greg-morrow-chief-marketing-officer-announces-inducement-grants-nasdaq-listing-rule-5635c4/ 2018-01-30T02:46:12+00:00 https://rheveramed.com/news/endologix-inc-completes-patient-enrollment-elevate-ide-clinical-study/ 2018-02-05T23:59:50+00:00 https://rheveramed.com/news/john-mcdermott-steps-chief-executive-officer-endologix-inc/ 2018-02-22T05:33:16+00:00 https://rheveramed.com/news/endologix-inc-announces-enrollment-first-patient-evas2-ide-clinical-study-nellix-endovascular-aneurysm-sealing-system/ 2018-03-06T00:23:42+00:00 https://rheveramed.com/news/endologix-reports-positive-results-global-encore-analysis-polymer-endovascular-aneurysm-repair-evar-using-ovation-abdominal-stent-graft-systems/ 2018-03-20T02:53:52+00:00 https://rheveramed.com/news/endovascular-aneurysm-sealing-evas-nellix-system-associated-higher-survival-traditional-endovascular-aneurysm-repair-evar-new-study/ 2018-04-25T20:00:59+00:00 https://rheveramed.com/news/endologix-appoints-john-onopchenko-chief-executive-officer/ 2018-05-03T03:56:00+00:00 https://rheveramed.com/news/endologix-appoints-jeffry-fecho-chief-quality-officer/ 2018-06-26T03:37:25+00:00 https://rheveramed.com/news/endologix-reports-positive-1-year-results-ovation-lucy-study/ 2018-06-28T21:31:26+00:00 https://rheveramed.com/news/endologix-appoints-jeffrey-s-brown-chief-operations-officer/ 2018-08-15T21:29:22+00:00 https://rheveramed.com/news/endologix-announces-third-quarter-preliminary-revenue-results-raises-low-end-2018-revenue-guidance-range/ 2018-10-03T02:45:29+00:00 https://rheveramed.com/news/endologix-honors-innovators-aortic-therapy-veithsymposium/ 2018-11-16T02:08:34+00:00 https://rheveramed.com/news/endologix-takes-decisive-action-optimize-patient-outcomes-ensuring-nellix-system-used-within-current-indications/ 2019-01-04T12:40:32+00:00 https://rheveramed.com/news/endologix-appoints-john-d-zehren-chief-commercial-officer/ 2019-01-10T14:28:27+00:00 https://rheveramed.com/news/endologix-provides-update-previously-announced-voluntary-nellix-system-recall/ 2019-01-23T04:03:17+00:00 https://rheveramed.com/news/endologix-announces-equity-financing-52-million-debt-restructuring-addressing-2020-maturities-financial-covenants/ 2019-04-02T21:54:29+00:00 https://rheveramed.com/news/endologix-announces-reinstatement-ce-mark-nellix-endovascular-aneurysm-sealing-system/ 2019-06-07T04:00:07+00:00 https://rheveramed.com/news/endologix-receives-ide-approval-nellix-chimney-endovascular-aneurysm-sealing-protocol/ 2019-08-10T00:48:09+00:00 https://rheveramed.com/news/endologix-announces-exclusive-distributor-agreement-boston-scientific-chinese-market/ 2019-08-10T00:50:32+00:00 https://rheveramed.com/news/endologix-receives-fda-approval-alto-abdominal-stent-graft-system/ 2020-03-17T02:40:25+00:00 https://rheveramed.com/news/endologix-adds-jane-e-kiernan-board-directors/ 2020-03-17T21:49:24+00:00 https://rheveramed.com/news/endologix-appoints-tim-benner-chief-commercial-officer/ 2020-04-15T05:15:24+00:00 https://rheveramed.com/news/endologix-announces-completion-enrollment-evas2-confirmatory-clinical-study-evaluate-nellix-endovascular-aneurysm-sealing-system/ 2020-05-12T04:36:23+00:00 https://rheveramed.com/news/endologix-announces-first-commercial-implant-alto-abdominal-stent-graft-system-official-start-u-s-commercial-release/ 2020-07-30T20:28:01+00:00 https://rheveramed.com/news/endologix-receives-ce-mark-alto-abdominal-stent-graft-system/ 2020-08-05T20:48:45+00:00 https://rheveramed.com/news/endologix-announces-first-commercial-implant-alto-abdominal-stent-graft-system-outside-united-states/ 2020-09-03T00:17:27+00:00 https://rheveramed.com/news/endologix-launches-alto-abdominal-stent-graft-system-europe/ 2020-10-16T01:14:50+00:00 https://rheveramed.com/news/endologix-llc-announces-acquisition-of-pq-bypass-inc/ 2021-04-13T18:05:05+00:00 https://rheveramed.com/news/endologix-llc-announces-launch-of-alto-abdominal-stent-graft-system-in-canada-and-argentina-company-expands-global-reach-with-latest-endovascular-aneurysm-repair-evar-technology/ 2021-05-11T20:00:25+00:00 https://rheveramed.com/news/endologix-llc-receives-fda-breakthrough-device-designation-for-chevastm-system/ 2021-07-19T22:28:25+00:00 https://rheveramed.com/news/endologix-initiates-randomized-study-of-alto-abdominal-stent-graft-system/ 2021-09-29T22:42:29+00:00 https://rheveramed.com/news/endologix-names-dr-matthew-thompson-president-and-ceo/ 2021-11-10T20:00:03+00:00 https://rheveramed.com/news/endologix-announces-completion-of-enrollment-in-the-torus-2-study-for-pad-in-sfa/ 2021-11-23T20:00:24+00:00 https://rheveramed.com/news/endologix-receives-ce-mark-certification-under-eu-mdr-for-afx2-endovascular-aaa-system/ 2022-08-04T18:00:53+00:00 https://rheveramed.com/news/elevate-ide-study-highlights-the-safety-and-effectiveness-of-the-alto-abdominal-stent-graft-system-in-one-year-results-data-to-be-presented-at-2022-veithsymposium/ 2022-10-21T04:10:46+00:00 https://rheveramed.com/news/endologix-reports-five-year-data-of-the-leopard-trial-at-2022-vascular-interventional-advances-viva-conference/ 2022-11-04T01:36:13+00:00 https://rheveramed.com/news/endologix-announces-12-month-results-of-detour-2-trial-at-2022-viva-late-breaking-clinical-trial-session/ 2022-11-12T04:17:22+00:00 https://rheveramed.com/news/endologix-receives-fda-approval-of-pma-supplement-for-afx2-system/ 2022-12-08T01:49:00+00:00 https://rheveramed.com/news/endologix-wins-medical-device-engineering-breakthrough-award-in-7th-annual-medtech-breakthrough-awards-program/ 2023-05-05T23:22:21+00:00 https://rheveramed.com/news/endologix-inc-comments-recent-fda-update-type-iii-endoleaks-afx-endovascular-aaa-system/ 2023-06-04T03:25:14+00:00 https://rheveramed.com/wp-content/uploads/2023/06/Screen-Shot-2020-10-20-at-9.49.12-AM.png https://rheveramed.com/wp-content/uploads/2023/06/Screen-Shot-2020-10-20-at-9.49.12-AM.png https://rheveramed.com/news/test-another/ 2023-06-07T02:00:58+00:00 https://rheveramed.com/wp-content/uploads/2023/06/box_grid.jpg https://rheveramed.com/news/five-year-results-of-the-leopard-trial-published-in-the-journal-of-vascular-surgery-jvs/ 2023-06-09T15:47:36+00:00 https://rheveramed.com/news/endologix-announces-150th-patient-enrolled-in-jaguar-randomized-controlled-trial/ 2023-06-09T15:48:16+00:00 https://rheveramed.com/news/endologix-announces-that-scott-ward-joins-board-of-directors/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-that-art-taylor-joins-board-of-directors/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-initiates-percutaneous-transmural-arterial-bypass-ptab1-post-market-study/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-appoints-mike-mathias-as-chief-commercial-officer/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-to-present-at-upcoming-lsi-us-24-emerging-medtech-summit/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-1000-patients-treated-with-the-detour-system/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-first-patients-treated-with-the-detour-system-advancing-treatment-for-complex-peripheral-artery-disease/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-receives-fda-approval-of-the-detour-system-to-treat-long-complex-superficial-femoropopliteal-lesions-in-patients-with-pad/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-that-lucas-buchanan-joins-board-of-directors/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-the-u-s-centers-for-medicare-medicaid-services-granted-a-new-technology-add-on-payment-for-the-detour-system/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/3-year-detour2-results-demonstrate-sustained-symptom-relief-and-limb-preservation-in-complex-sfa-disease/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-reports-12-month-data-from-detour-2-clinical-trial-at-2022-vascular-annual-meeting/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-that-scott-huennekens-joins-board-of-directors/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-submits-premarket-approval-pma-application-to-fda-for-the-detourtm-system/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-appointment-of-steve-deitsch-to-board-of-directors/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologixs-detourtm-system-earns-spot-in-local-and-national-award-forums-nominated-for-prix-galien-usas-best-medical-technology/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-results-of-pooled-analysis-of-detour1-and-detour2-studies-at-2023-viva-late-breaking-clinical-trial-session/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-to-present-in-two-upcoming-healthcare-conferences/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-the-u-s-centers-for-medicare-medicaid-services-granted-a-transitional-pass-through-tpt-payment-for-the-detourtm-system/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-acquires-pounce-thrombectomy-system-expanding-its-vascular-intervention-portfolio/ 2026-09-29T21:24:35+00:00 https://rheveramed.com/news/endologix-announces-24-month-results-of-detour-2-study-at-2023-vascular-annual-meeting/ 2026-09-29T21:28:29+00:00 https://rheveramed.com/news/endologix-appoints-andrew-davis-as-chief-commercial-officer/ 2026-09-29T21:28:29+00:00 https://rheveramed.com/news/one-year-results-of-the-detour2-trial-published-in-the-journal-of-vascular-surgery-jvs/ 2026-09-29T21:28:29+00:00 https://rheveramed.com/news/4244/ 2026-09-29T21:28:29+00:00 https://rheveramed.com/news/endologix-announces-36-month-results-of-detour2-study-at-2024-viva-late-breaking-clinical-trial-session/ 2026-09-29T21:28:29+00:00 https://rheveramed.com/news/endologix-announces-leadership-transition/ 2026-09-29T21:28:29+00:00 https://rheveramed.com/news/fda-classifies-previous-endologix-afx-safety-notice-class-recall/ 2026-10-04T04:31:44+00:00 https://rheveramed.com/news/endologix-rebrands-as-rhevera-medical/ 2026-10-05T17:05:26+00:00